VIDEO:

HER2-Targeted Combination Delays Disease Growth

Researchers find a combination of HER2-targeted drugs, Herceptin (trastuzumab) and the novel HER2 inhibitor pertuzumab, delay cancer growth in metastatic breast cancer. [WATCH]

ARTICLE:

Afinitor Impresses in Advanced Breast Cancer

Researchers are finding that Afinitor (exemestane), a drug approved for advanced kidney cancer, could also be useful for advanced breast cancer as a recent study showed it slowed the disease from progressing. [READ]

VIDEO:

Test Could Spare Some DCIS Patients Radiation Therapy

Research shows that a variation of the Oncotype DX test could help physicians decide if certain patients diagnosed with ductal carcinoma in situ (DCIS) need radiation therapy or not. [WATCH]

VIDEO:

Complications with Brachytherapy in Breast Cancer

Researchers have found that a quicker form of radiation delivered inside the breast has higher complications and mastectomy rates than traditional breast radiation. [WATCH]

ARTICLE:

Novel Hormone Therapy Combination Shown to Prolong Survival

The hormone therapy, fulvestrant, combined with the aromatase inhibitor anastrozole improves survival in postmenopausal patients with hormone-positive metastatic breast cancer. [READ]

Blogs

DEBU TRIPATHY, MD

An update on the Cancer Genome Atlas for breast cancer

The Cancer Genome Atlas (TCGA) and International Genome Consortium (IGC) are embarking on a massive project to obtain broad scale gene sequencing, RNA profiles, and functional protein information on breast tumors. This will be used to assemble a comprehensive database that can be immediately shared and "mined" to obtain important clues to the triggers of cancer and its vulnerabilities that can be exploited for therapy. [MORE]

ELIZABETH WHITTINGTON

Breast Cancer and the Environment Report offers research roadmap

The release of the Institute of Medicine's Breast Cancer and the Environment: A Life Course Approach report has generated quite a bit of interest. Many were expecting information on BPA, pollution and cosmetics; what we get is that there needs to be more research. [MORE]

SUSAN MCCLURE

Fertility takes center stage at SABCS

Survivors often experience depression and anxiety because of cancer-related sterility. Fortunately for me, I was already married and a mother when I learned that I had cancer. That said, at 35, I was devastated when my oncologist told me that I wasn't going to be able to have more children. [MORE]

THANK YOU!

CURE would like to thank each of the following non-profit partners for helping to share the information in these updates with their networks. We encourage you to visit their websites and learn about these national and local resources that are available to you.

• American Cancer Society
• FORCE
• MyLifeLine.org
• SHARE Cancer Support
• Sharsheret
• The Sisters Network of Solano County
• BreastCancerTrials.org

More News

• Zometa's survival benefit confirmed
• Many elderly screened for cancer despite doubts
• Memory issues after cancer may not be due to chemo
• Pertuzumab could alter breast cancer treatment
• Quicker radiation therapy doubles mastectomy risk
• Vaccine promising against breast cancer recurrence

Community

• How did you get involved in advocacy? Tell us your mission and how it's changed both you and your community.
• SABCS, while a scientific research meeting, has a large advocate attendance. How do you think their presence affects the overall feel of the meeting?
• Side effects and late effects of chemotherapy
• CURE Message Board

Become a fan of CURE on Facebook.

Follow CURE on Twitter.

Send feedback to editor@curetoday.com.

Sign up for our email newsletters, which you can now personalize by tumor type, survivorship or caregiver status.

This email was sent to you because you have provided your email address to CURE. CURE is committed to protecting your privacy, and no information about our subscribers is sold to any outside party.

Please add enews@curetoday.com to your address book or safe sender list to ensure this email is delivered to your inbox.

2011 CURE Media Group. All rights reserved. Terms of Use

Disclaimer: CURE does not provide medical, diagnostic or treatment advice.